Hum. Reprod. Advance Access originally published online on December 22, 2007
Human Reproduction 2008 23(3):481-492; doi:10.1093/humrep/dem327
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fast track
Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis



1 Department of Embryology and Genetics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 2 Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 3 Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium 4 Veeda Clinical Research, Koning Albertlaan 160, 1082 Brussels, Belgium
5 Correspondence address. Tel: +32-2-477-60-73; Fax: +32-2-477-68-60; E-mail: karen.sermon{at}uzbrussel.be
BACKGROUND: Preimplantation genetic diagnosis or screening (PGD, PGS) involves embryo biopsy on Day 3. Opting for one- or two-cell biopsy is a balance between the lowest risk for misdiagnosis on the one hand and the highest chance for a pregnancy on the other hand.
METHODS: A prospective controlled trial was designed and 592 ICSI cycles were randomly assigned to the one-cell (group I) or the two-cell group (group II). Primary outcomes were diagnostic efficiency and embryonic development to delivery with live birth (analysed by cycle). The false-positive rate for the PCR cycles is presented as a secondary outcome (analysed by embryo).
RESULTS: A strong significant correlation was observed between embryonic developmental stage on Day 3 and post-biopsy in vitro development on Day 5 (P < 0.0001). The influence of the intervention on Day 3 was less significant (P = 0.007): the biopsy of one cell is less invasive than the biopsy of two cells. PCR diagnostic efficiency was 88.6% in group I and 96.4% in group II (P = 0.008). For the fluorescence in situ hybridization (FISH) PGD cycles no significant difference in efficiency was obtained (98.2 and 97.5% in group I and II, respectively). Similar delivery rates with live birth per started cycle were obtained [58/287 or 20.2% in group I versus 52/303 or 17.2% in group II, P = 0.358; the absolute risk reduction = 3.05%; 95% confidence interval (CI): –3.24, 9.34]. Post-PGD PCR reanalysis showed six false positives in 97 embryos (6.2%) in group II and none in group I (91 embryos reanalysed). No false negatives were found.
CONCLUSIONS: While removal of two blastomeres decreases the likelihood of blastocyst formation, compared with removal of one blastomere, Day 3 in vitro developmental stage is a stronger predictor for Day 5 developmental potential than the removal of one or two cells. The biopsy of only one cell significantly lowers the efficiency of a PCR-based diagnosis, whereas the efficiency of the FISH PGD procedure remains similar whether one or two cells are removed. Delivery rates with live birth per started cycle were not significantly different.
Key words: preimplantation genetic diagnosis/preimplantation genetic screening/embryo biopsy/embryo development/diagnostic efficiency
The first three authors have equally contributed. Submitted on May 8, 2007; resubmitted on August 13, 2007; accepted on September 20, 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. De Vos, C. Staessen, M. De Rycke, W. Verpoest, P. Haentjens, P. Devroey, I. Liebaers, and H. Van de Velde Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers Hum. Reprod., December 1, 2009; 24(12): 2988 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hanson, T. Hardarson, K. Lundin, C. Bergh, T. Hillensjo, J. Stevic, C. Westin, U. Selleskog, L. Rogberg, and M. Wikland Re-analysis of 166 embryos not transferred after PGS with advanced reproductive maternal age as indication Hum. Reprod., November 1, 2009; 24(11): 2960 - 2964. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Liebaers, S. Desmyttere, W. Verpoest, M. De Rycke, C. Staessen, K. Sermon, P. Devroey, P. Haentjens, and M. Bonduelle Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis Hum. Reprod., August 27, 2009; (2009) dep298v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Devroey, B.C.J.M. Fauser, K. Diedrich, and on behalf of the Evian Annual Reproduction (EVAR) Approaches to improve the diagnosis and management of infertility Hum. Reprod. Update, July 1, 2009; 15(4): 391 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vanneste, C. Melotte, S. Debrock, T. D'Hooghe, H. Brems, J.P. Fryns, E. Legius, and J.R. Vermeesch Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions Hum. Reprod., June 1, 2009; 24(6): 1522 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wilton, A. Thornhill, J. Traeger-Synodinos, K.D. Sermon, and J.C. Harper The causes of misdiagnosis and adverse outcomes in PGD Hum. Reprod., May 1, 2009; 24(5): 1221 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ubaldi and L. Rienzi Possible impact of LH-containing gonadotrophins on diploidy rates in preimplantation embryos Hum. Reprod., May 1, 2009; 24(5): 1238 - 1239. [Full Text] [PDF] |
||||
![]() |
A. Weghofer, S. Munne, W. Brannath, D.H. Barad, J. Cohen, and N. Gleicher Reply: Possible impact of LH-containing gonadotrophins on diploidy rates in preimplantation embryos Hum. Reprod., May 1, 2009; 24(5): 1239 - 1240. [Full Text] [PDF] |
||||
![]() |
H. Van de Velde, M. De Rycke, C. De Man, K. De Hauwere, F. Fiorentino, S. Kahraman, G. Pennings, W. Verpoest, P. Devroey, and I. Liebaers The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing Hum. Reprod., March 1, 2009; 24(3): 732 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yakin and B. Urman What next for preimplantation genetic screening? A clinician's perspective Hum. Reprod., August 1, 2008; 23(8): 1686 - 1690. [Abstract] [Full Text] [PDF] |
||||

